Skip to main content
Clinical Trials/EUCTR2018-003233-14-FR
EUCTR2018-003233-14-FR
Active, not recruiting
Phase 1

Evaluation of the neonatal autonomic stress during intubations under Propofol in a population of premature infants under 33 w’GA - PROPOSURF

CHU de Saint Etienne0 sites30 target enrollmentAugust 23, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
population of premature infants under 33 w’GA requiring intubation for the administration of exogenous surfactant
Sponsor
CHU de Saint Etienne
Enrollment
30
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 23, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU de Saint Etienne

Eligibility Criteria

Inclusion Criteria

  • Preterm neonates (\< 33 weeks GA) requiring in the first week of life, an elective tracheal intubation for surfactant administration by INSURE or LISA methods.
  • Collected Consent from parents
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Preterm neonates with Intraventricular hemorrhage grade III \& IV
  • Preterm neonates with hemodynamic instability
  • Preterm neonates with congenital heart disease
  • Preterm neonates with severe congenital malformation
  • Preterm neonates already sedated and/or under invasive mechanical ventilation

Outcomes

Primary Outcomes

Not specified

Similar Trials